New Frontier: Developing Outcome Measures for Pre-dementia Trials
Alzheimer Network (DIAN), Alzheimer’s Prevention Initiative (API), and the Anti-Amyloid Treatment in
Upcoming Webinars
No Upcoming Webinars AvailableALL WEBINARS
151 RESULTS
You searched herpes-simplex-and-alzheimers-time-thinkagain
Sort By:
- Most Recent
- Most Commented
- Most Relevant
Using ADNI Data—Online Training, Part 1
On 4 April 2013, the Alzheimer's Disease Neuroimaging Initiative biostatistics core held the
How Cognitive Stimulation Might Protect Against Aβ Oligomers
epidemiological studies suggest that cognitive and social stimulation can ward off Alzheimer’s disease (see, e.g.,
Neuroinflammation—A Prelude to Alzheimer's?
slowing or halting Alzheimer's disease by suppressing the immune system and preventing
International Student Workshop on AD
What makes a good grant proposal in Alzheimer’s research? How to develop and present it? What are
Latest γ-Secretase Substrate Involved in Synaptic Stability, Autism?
discussed potential implications for Alzheimer’s disease and other brain disorders. We tip our hats to Cell
Weeding Mendel’s Garden: Can We Hoe Dubious Genetic Associations?
various neurodegenerative diseases, including Alzheimer’s, Parkinson’s, frontotemporal dementias, and
“Network Epicenters” in Healthy Connectome Predict Dementia
light any time soon on the tendency of Alzheimer's, frontotemporal dementia, Parkinson's, and
AD in the Oldest Old—What Does Aβ Have to Do With It?
diseases such as Alzheimer’s and stroke, yet science knows little about them. Their number is set to
Who Should Use the New Diagnostic Guidelines? The Debate Continues
of prodromal/preclinical Alzheimer’s disease, plus criteria for a research and clinical diagnosis of
Adding Dynamics and Nuance to Alzheimer’s Staging
Alzheimer’s disease brain. The relationships among these changes differ depending on brain region and stage of
Evolution of AD Trials
Conference on Clinical Trials on Alzheimer's Disease was filled beyond the capacity of its venue,
Clearing the Fog Around Aβ Oligomers
to Alzheimer’s disease. Researchers studying tau and α-synuclein may confront similar challenges
Resolving Controversies on the Path to AD Therapeutics
and Bart de Strooper titled “The amyloid cascade hypothesis for Alzheimer’s Disease: an appraisal for
Slow Aβ; Clearance Is ApoE4’s Modus Operandi in Late-Onset AD
metabolism before and after plaque formation in a mouse model of Alzheimer's disease. Neurobiol Dis.
Have a topic idea for a webinar? We would love to hear it. Send an email to webinars [at] alzforum [dot] org.